Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib

OBJECTIVE: To determine the rate of unintentional monotherapy (UM; switching to monotherapy from combination therapy of patients' own volition) in rheumatoid arthritis patients receiving tofacitinib and to evaluate tofacitinib survival rate. METHODS: This national, multicenter study included pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Inanc, Nevsun, Abacar, Kerem Y., Ozturk, Mehmet A., Tufan, Abdurrahman, Karadeniz, Hazan, Sari, Ismail, Can, Gercek, Erez, Yesim, Pehlivan, Yavuz, Dalkilic, Huseyin E., Ocak, Tugba, Cefle, Ayse, Yazici, Ayten, Senel, Abdurrahman S., Akar, Servet, Durak-Ediboğlu, Elif, Koca, Suleyman S., Piskin-Sagir, Rabia, Yilmaz, Sema, Gulcemal, Semral, Soysal-Gunduz, Ozgul, Basibuyuk, Canberk S., Alkan, Serdar, Cesur, Teoman Y., Onen, Fatos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662607/
https://www.ncbi.nlm.nih.gov/pubmed/37724891
http://dx.doi.org/10.1097/RHU.0000000000002026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662607/
https://www.ncbi.nlm.nih.gov/pubmed/37724891
http://dx.doi.org/10.1097/RHU.0000000000002026

Ejemplares similares